Management provides a detailed review of PGRN for Frontotemporal Dementia with broad additional opportunities including Alzheimer’s Disease on a conference call to be held on December 13 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ALEC:
- Alector initiated with bullish view at Deutsche Bank, here’s why
- Alector to Host Two Virtual Research and Development Events Highlighting TREM2 and Progranulin Programs
- Alector price target lowered to $9 from $10 at Mizuho
- Alector to Participate in the Stifel Healthcare Conference
- Alector reports Q3 EPS (53c), consensus (66c)
